- Home
- SCSC vs ORIC Comparison
SCSC vs ORIC Comparison
Compare SCSC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCSC | ORIC |
|---|---|---|
| Founded | 1992 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 892.3M | 973.9M |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SCSC | ORIC |
|---|---|---|
| Price | $41.83 | $9.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 12 |
| Target Price | ★ $43.00 | $19.50 |
| AVG Volume (30 Days) | 156.6K | ★ 1.3M |
| Earning Date | 01-29-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.79 | N/A |
| EPS | ★ 3.20 | N/A |
| Revenue | ★ $3,004,880,000.00 | N/A |
| Revenue This Year | $5.96 | N/A |
| Revenue Next Year | $5.06 | N/A |
| P/E Ratio | $13.11 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $28.75 | $3.90 |
| 52 Week High | $53.90 | $14.93 |
Technical Indicators
Market Signals| Indicator | SCSC | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 54.02 | 25.89 |
| Support Level | $40.06 | $10.45 |
| Resistance Level | $43.41 | $12.50 |
| Average True Range (ATR) | 1.18 | 0.69 |
| MACD | 0.14 | -0.19 |
| Stochastic Oscillator | 58.21 | 8.42 |
Price Performance
Historical ComparisonAbout SCSC ScanSource Inc.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.